Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer.
NKX2-1, encoding a homeobox transcription factor, is amplified in approximately 15% of non-small cell lung cancers (NSCLC), where it is thought to drive cancer cell proliferation and survival. However, its mechanism of action remains largely unknown. To identify relevant downstream transcriptional t...
Main Authors: | Nicole Clarke, Jewison Biscocho, Kevin A Kwei, Jean M Davidson, Sushmita Sridhar, Xue Gong, Jonathan R Pollack |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4640868?pdf=render |
Similar Items
-
Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
by: Nicholas Barasch, et al.
Published: (2017-01-01) -
Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development
by: Angela J Churchill, et al.
Published: (2017-01-01) -
Notch and retinoic acid signals regulate macrophage formation from endocardium downstream of Nkx2-5
by: Norika Liu, et al.
Published: (2023-09-01) -
Suppression of Lung Adenocarcinoma Progression by Nkx2-1
by: Winslow, Monte Meier, et al.
Published: (2011) -
Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target
by: Watanabe, Hideo, et al.
Published: (2014)